top of page
Search


Insulin is About to Get Cheaper…Or Is It?
The House on Thursday passed legislation to cap the cost of insulin at $35 a month. Cost sharing for beneficiaries in private plans would...
Scripta
Apr 1, 2022


Shared Decision Making in Healthcare
Before buying a product online, most people immediately jump to the review section. While scrolling, it’s typical to come across a...
Angel Rinaldi
Apr 30, 2021


Prior Authorizations Make It Difficult for Patients to Get the Meds They Need
In our current world of healthcare, patients encounter various roadblocks when filling their prescriptions at the pharmacy. More...
Angel Rinaldi
Apr 23, 2021


Report on Drugs with Unsupported Price Increases
ICER, is best known as the nation’s independent watchdog on drug pricing, issues drug assessment reports include a full analysis of how...
Scripta
Oct 11, 2019


Don’t Be Afraid of Your PBM
Even CVS Caremark has realized that constant, consistent oversight is the only way to address hyperinflated drug prices. For years, drug...
Scripta
Sep 19, 2019


Drug Coupons Have Everyone Bamboozled
The government issued a confusing new rule designed to curb the use of drug manufacturer coupons, then delayed its implementation until...
Scripta
Sep 9, 2019


“Talk to Your Doctor” and Save?
By controlling the conversation we have in the doctor’s office, Big Pharma is able to sell us drugs we don’t need at prices we can’t...
Scripta
Aug 28, 2019


Authorized Generics Explained
Drugmakers’ latest gambit explained: Designed to extend market exclusivity and stifle or delay competition, authorized generics can be...
Scripta
Aug 13, 2019


A Brave (Expensive) New World for Payers
We are in an era of million-dollar drugs. As expensive gene therapies become available, concerns among payers and physicians turn to cost...
Scripta
Aug 8, 2019
Blog
bottom of page
